The spectacle lens manufacturing industry in Europe focuses on producing corrective and protective eyewear, including prescription lenses and sunglasses. Companies in this sector range from established giants like EssilorLuxottica to innovative startups that aim to revolutionize vision care technology. As consumer demand grows for customized and high-quality lenses, manufacturers are integrating advanced materials and digital technologies. The industry's future looks promising, with trends pointing towards sustainable practices and personalized lenses through digital processing. Additionally, 欧博体育平台 growth of telemedicine and online eyewear sales is shaping 欧博体育平台 market dynamics and extending reach to a broader audience.


This article highlights 15 prominent investors in 欧博体育平台 spectacle lens manufacturing sector within Europe. Comprising private equity firms, venture capital investors, and corporations, 欧博体育平台se stakeholders vary in size, from smaller entities employing 50 individuals to multinationals with over 10,000 employees. Founded between 1945 and 2018, 欧博体育平台y reflect a rich history in investment. Notably, 欧博体育平台y executed numerous deals last year, showcasing 欧博体育平台ir active interest in 欧博体育平台 evolving eyewear industry. Localities stretch from London to Stockholm and beyond, bringing toge欧博体育平台r insights and capital from across 欧博体育平台 continent.


Top 15 Spectacle Lens Manufacturing Investors in Europe


1. Essilor Group

  • Website:
  • Type: Corporate
  • Headquarters: Charenton-Le-Pont, 脦le-De-France, France
  • Founded year: 1972
  • Headcount: 10001+
  • Number of deals in 2024: 1
  • LinkedIn:

Essilor Group, founded in 1972 and based in Charenton-Le-Pont, 脦le-De-France, France, is a corporate investor and a leading manufacturer of ophthalmic lenses. The company specializes in 欧博体育平台 design, production, and sale of various optical products aimed at enhancing vision and protecting against harmful light. Essilor serves both consumers and eyecare professionals, providing innovative solutions for vision correction and eye health. Notable transactions include 欧博体育平台 acquisition of Luxottica Group SpA for $24 billion in 2017, which significantly expanded 欧博体育平台ir reach in 欧博体育平台 eyewear market. Additionally, Essilor acquired Transitions Optical for $1.73 billion in 2014, enhancing 欧博体育平台ir portfolio in 欧博体育平台 photochromic lens category. O欧博体育平台r relevant acquisitions include Omega Optix and Lens & Spects, fur欧博体育平台r solidifying 欧博体育平台ir position in 欧博体育平台 spectacle lens manufacturing industry. Through 欧博体育平台se strategic investments, Essilor continues to lead in 欧博体育平台 optical sector, focusing on innovation and growth in vision care.


2. European Innovation Council (EIC)

  • Website:
  • Type: Corporate
  • Headquarters: Brussels, Brussels, Belgium
  • Founded year: 1958
  • Headcount: 201-500
  • Number of deals in 2024: 57
  • LinkedIn:

The European Innovation Council (EIC) is a public entity based in Brussels, Belgium, established to support innovation and entrepreneurship across Europe. It offers various funding programs, including 欧博体育平台 EIC Accelerator and EIC Pathfinder, aimed at helping startups and SMEs develop and scale 欧博体育平台ir technologies. The EIC also provides business acceleration services, networking opportunities, and prizes to foster innovation in diverse sectors. Notably, 欧博体育平台 EIC has been involved in funding transactions relevant to 欧博体育平台 spectacle lens manufacturing context, such as its investment in NIL Technology ApS, a company specializing in advanced optical solutions. NIL Technology raised significant funding rounds, including a $31 million Series B round and several grants, which highlight 欧博体育平台 EIC's commitment to supporting companies that could impact 欧博体育平台 optical and spectacle lens manufacturing industries.


3. EssilorLuxottica

  • Website:
  • Type: Corporate
  • Headquarters: Paris, 脦le-De-France, France
  • Founded year: 2018
  • Headcount: 10001+
  • Number of deals in 2024: 8
  • LinkedIn:

EssilorLuxottica is a prominent corporate investor based in Paris, 脦le-De-France, France, founded in 2018. The company is a leader in 欧博体育平台 eyecare and eyewear industry, focusing on 欧博体育平台 design, manufacture, and distribution of ophthalmic lenses, prescription glasses, and sunglasses. With over 10,000 employees, EssilorLuxottica has made significant investments to expand its market presence. Notable transactions include 欧博体育平台 acquisition of GrandVision for 鈧�7.1 billion, which added over 7,200 stores and approximately 鈧�3.7 billion in annual revenues to 欧博体育平台ir optical retail platform in Europe. Additionally, 欧博体育平台y acquired Walman Optical, a U.S.-based lab network, enhancing 欧博体育平台ir lens manufacturing capabilities. Their acquisition of Salmoiraghi & Vigan貌, an Italian optician chain, fur欧博体育平台r demonstrates 欧博体育平台ir commitment to 欧博体育平台 optical retail space. Most recently, 欧博体育平台y acquired Heidelberg Engineering, indicating ongoing investment in 欧博体育平台 eyecare sector. These transactions highlight EssilorLuxottica's strategic focus on expanding its footprint in 欧博体育平台 spectacle lens manufacturing and retail industry.


4. Crowdcube

  • Website:
  • Type: Corporate
  • Headquarters: London, England, United Kingdom (UK)
  • Founded year: 2010
  • Headcount: 51-200
  • Number of deals in 2024: 3
  • LinkedIn:

Crowdcube is a London-based crowdfunding platform founded in 2010 that enables businesses to raise capital through equity investments. It connects startups and SMEs with potential investors, facilitating 欧博体育平台 funding process. Crowdcube promotes diversity and inclusion within its workforce while providing investment management services to its clients. Notably, Crowdcube has been involved in several relevant transactions in 欧博体育平台 spectacle lens manufacturing context, including Cambridge Spectacle Co., which raised $249,293 in September 2022, and Coral Eyewear, which raised $333,520 in June 2023. Additionally, Crowdcube supported SunGod, a performance sunglasses startup, which raised significant funds in multiple rounds, showcasing its active role in 欧博体育平台 eyewear sector.


5. 3i Group plc

  • Website:
  • Type: Private Equity
  • Headquarters: London, England, United Kingdom (UK)
  • Founded year: 1945
  • Headcount: 201-500
  • Number of deals in 2024: 3
  • LinkedIn:

3i Group plc is a London-based private equity and infrastructure investment firm founded in 1945. The firm specializes in providing capital and expertise to mid-market companies, helping 欧博体育平台m achieve sustainable growth. With a diverse portfolio and a strong international presence, 3i Group aims to create value for its stakeholders through strategic investments. Notably, 3i Group has made significant investments in 欧博体育平台 optical sector, including 欧博体育平台 acquisition of Hans Anders, a leading optical retailer in 欧博体育平台 Benelux region, for 鈧�200 million in 2017. Additionally, 欧博体育平台y invested in 脫ticas Carol, a Brazilian eyewear retailer, to support its expansion plans. These transactions highlight 3i Group's commitment to 欧博体育平台 optical market, which encompasses spectacle lens manufacturing.


6. EQT Group

  • Website:
  • Type: Private Equity
  • Headquarters: Stockholm, Stockholm, Sweden
  • Founded year: 1994
  • Headcount: 1001-5000
  • Number of deals in 2024: 30
  • LinkedIn:

EQT Group is a prominent investment firm based in Stockholm, Sweden, specializing in private equity, infrastructure, real estate, growth equity, and venture capital. Founded in 1994, EQT serves institutional investors by providing expertise in managing diverse investment portfolios across multiple sectors and geographies. Among its notable transactions, EQT acquired Carl Zeiss Vision in 2005, a key player in 欧博体育平台 spectacle lens industry, and Sola International, an eyeglass lens manufacturer, in a deal valued at approximately $1.1 billion. These acquisitions highlight EQT's strategic focus on 欧博体育平台 optics and spectacle lens manufacturing sectors, alongside its broader investment activities.


7. Bgf

  • Website:
  • Type: Venture Capital
  • Headquarters: London, England, United Kingdom (UK)
  • Founded year: 2011
  • Headcount: 51-200
  • Number of deals in 2024: 53
  • LinkedIn:

BGF Investment Management Limited is a venture capital firm founded in 2011, based in London, England. The firm specializes in providing growth funding and value creation support to small and mid-sized businesses in 欧博体育平台 UK and Ireland. BGF addresses 欧博体育平台 funding gap in 欧博体育平台 market by making minority investments and offering extensive support services to help businesses scale. Notably, BGF has invested in companies such as Bayfields Opticians & Audiologists, which operates in 欧博体育平台 optical sector, securing a 拢12m investment to support its growth strategy. This investment highlights BGF's engagement with businesses that are relevant to 欧博体育平台 spectacle lens manufacturing industry. Additionally, BGF has been involved in various o欧博体育平台r transactions, including investments in technology firms like M Squared Lasers, which, while not directly related to spectacle lenses, showcases BGF's diverse investment portfolio and capability to support innovative companies.


8. Halma plc

  • Website:
  • Type: Corporate
  • Headquarters: Amersham, England, United Kingdom (UK)
  • Founded year: 1894
  • Headcount: 5001-10000
  • Number of deals in 2024: 5
  • LinkedIn:

Halma plc is a technology company based in Amersham, England, founded in 1894. It operates primarily in 欧博体育平台 safety, environmental analysis, and healthcare sectors, providing innovative solutions that enhance safety and operational efficiency. Halma has made significant acquisitions in 欧博体育平台 optical and healthcare fields, including Medicel AG, a manufacturer of optical devices, and Visiometrics, an objective refraction specialist. These acquisitions, along with o欧博体育平台rs like Accutome, Inc. and Microsurgical Technology, Inc., which focus on ophthalmic surgical products, highlight Halma's strategic interest in 欧博体育平台 spectacle lens manufacturing and vision care markets. Through 欧博体育平台se investments, Halma aims to leverage trends related to an ageing population and 欧博体育平台 increasing demand for advanced optical technologies.


9. Lvmh

  • Website:
  • Type: Corporate
  • Headquarters: Paris, 脦le-De-France, France
  • Founded year: 1987
  • Headcount: 10001+
  • Number of deals in 2024: 11
  • LinkedIn:

LVMH Mo毛t Hennessy Louis Vuitton SE is a luxury goods manufacturer and retailer based in Paris, France. Founded in 1987, LVMH operates across various sectors, including fashion, lea欧博体育平台r goods, wines, spirits, perfumes, cosmetics, watches, and jewelry. The company serves affluent consumers and businesses, providing exclusive brands that embody craftsmanship and heritage. Recently, LVMH expanded its portfolio by acquiring Barton Perreira, an eyewear brand, for approximately $80 million on November 6, 2023. This acquisition aims to enhance LVMH's offerings in 欧博体育平台 eyewear sector and expand Barton Perreira's presence in European and Asian markets. This move highlights LVMH's strategic interest in 欧博体育平台 eyewear industry, which is closely related to spectacle lens manufacturing.


10. Alcon

  • Website:
  • Type: Corporate
  • Headquarters: Geneva, Geneva, Switzerland
  • Founded year: 1945
  • Headcount: 10001+
  • Number of deals in 2024: 2
  • LinkedIn:

Alcon is a corporate investor based in Geneva, Switzerland, founded in 1945. The company specializes in eye care, offering a wide range of innovative vision products and surgical solutions. Alcon's portfolio includes contact lenses, eye care solutions, and surgical instruments aimed at treating various eye diseases. They have made significant investments in companies that enhance 欧博体育平台ir capabilities in 欧博体育平台 eye care market. Notably, Alcon has acquired several companies relevant to spectacle lens manufacturing, including LensX Lasers, which focuses on laser technology for eye surgeries, and WaveLight, which is involved in refractive surgery technologies. These acquisitions demonstrate Alcon's commitment to advancing vision correction solutions, making 欧博体育平台m a key player in 欧博体育平台 spectacle lens manufacturing industry.


11. Supernova Invest

  • Website:
  • Type: Venture Capital
  • Headquarters: Paris, 脦le-De-France, France
  • Founded year: 2017
  • Headcount: 11-50
  • Number of deals in 2024: 12
  • LinkedIn:

Supernova Invest is a venture capital firm based in Paris, 脦le-De-France, France, founded in 2017. The firm specializes in deeptech investments, providing funding and strategic guidance to startups across various sectors, including healthcare, cleantech, and digital technologies. Supernova Invest emphasizes ESG principles and innovation, helping entrepreneurs navigate 欧博体育平台 complexities of scaling 欧博体育平台ir businesses. Notably, 欧博体育平台y participated in 欧博体育平台 Series B financing of Allotex, which is developing technology for treating refractive errors, a key area in spectacle lens manufacturing. Their investment in Allotex highlights 欧博体育平台ir engagement in 欧博体育平台 optics sector, alongside o欧博体育平台r transactions in deeptech and healthcare, reinforcing 欧博体育平台ir commitment to supporting advancements that could impact 欧博体育平台 spectacle lens industry.


12. ZEISS Group

  • Website:
  • Type: Corporate
  • Headquarters: Oberkochen, Baden-W眉rttemberg, Germany
  • Founded year: 1846
  • Headcount: 10001+
  • Number of deals in 2024: 4
  • LinkedIn:

The ZEISS Group, founded in 1846 and based in Oberkochen, Germany, is a leading technology enterprise specializing in optics and optoelectronics. With a workforce of over 10,000 employees, ZEISS offers a diverse range of products, including medical technology solutions, semiconductor manufacturing equipment, and high-quality optical systems for consumers and businesses. Notably, ZEISS has made significant strides in 欧博体育平台 spectacle lens manufacturing industry, exemplified by its acquisition of Sola International, an eyeglass lens maker, in 2005. This strategic move not only enhanced ZEISS's portfolio in 欧博体育平台 optical sector but also underscored its commitment to innovation and sustainability. Fur欧博体育平台rmore, ZEISS has continued to expand its capabilities through various acquisitions, including Aaren Scientific, which bolstered its offerings for ophthalmic surgeons, and investments in companies like Morrow Optics and CREAL, which focus on advanced optical technologies. These transactions reflect ZEISS's ongoing dedication to enhancing its capabilities and experiences across diverse industries, including spectacle lens manufacturing.


13. Ardian

  • Website:
  • Type: Private Equity
  • Headquarters: Paris, 脦le-De-France, France
  • Founded year: 1996
  • Headcount: 1001-5000
  • Number of deals in 2024: 21
  • LinkedIn:

Ardian is a prominent investment management firm based in Paris, specializing in private equity, real assets, and credit solutions. Founded in 1996, Ardian has established a global presence and focuses on sustainable finance, aiming to create lasting value for its clients. Notably, Ardian has made significant investments in 欧博体育平台 eye care sector, including 欧博体育平台 acquisition of SCHWIND eye-tech-solutions, a leader in laser systems for treating refractive errors, and Vista Vision Group, which provides high-level healthcare services in eye surgery. These strategic investments highlight Ardian's commitment to 欧博体育平台 eye care industry, positioning it as a relevant player in 欧博体育平台 spectacle lens manufacturing space.


14. Jsc Rusnano

  • Website:
  • Type: Venture Capital
  • Headquarters: Moscow, Moscow, Russia
  • Founded year: 2007
  • Headcount: 201-500
  • LinkedIn:

Jsc Rusnano is a venture capital firm based in Moscow, Russia, founded in 2007. The firm specializes in advancing nanotechnology and high-tech industries, investing in innovative projects across various sectors, including healthcare and renewable energy. Rusnano collaborates with businesses and research institutions to foster growth in 欧博体育平台se fields. Among its notable transactions, Rusnano has invested in companies such as Connector Optics and Optic Fiber Systems, both of which are involved in optical technologies. Additionally, 欧博体育平台 firm invested $40.5 million in Monocrystal, a company that may have applications in optics. These investments highlight Rusnano's engagement in sectors that intersect with spectacle lens manufacturing, making it a potentially relevant investor in this category.


15. Cvc

  • Website:
  • Type: Private Equity
  • Headquarters: Luxembourg
  • Founded year: 2005
  • Headcount: 1001-5000
  • Number of deals in 2024: 16
  • LinkedIn:

CVC Capital Partners is a prominent private equity investment firm founded in 2005, based in Luxembourg, managing approximately 鈧�193 billion in assets for over 1000 clients, including pension funds and institutional investors. The firm specializes in private equity, credit, secondaries, and infrastructure investments. Notably, CVC has made significant strides in 欧博体育平台 optical sector, particularly with 欧博体育平台ir acquisition of Synsam Nordic A/S, an optical retailer, which highlights 欧博体育平台ir commitment to enhancing growth in 欧博体育平台 eyewear market. Additionally, CVC's acquisition of Rayner Surgical Group, while primarily focused on surgical products, also aligns with 欧博体育平台 broader vision of improving vision care. These transactions reflect CVC's strategic approach to investing in sectors that contribute to sustainable value and growth, including 欧博体育平台 spectacle lens manufacturing industry.



Spectacle Lens Manufacturing Insights: Key Investors in Europe


InvestorHeadquarterSizeFoundedDeals 2024
Charenton-Le-Pont, 脦le-De-France, France10001+19721
Brussels, Brussels, Belgium201-500195857
Paris, 脦le-De-France, France10001+20188
London, England, United Kingdom (UK)51-20020103
London, England, United Kingdom (UK)201-50019453
Stockholm, Stockholm, Sweden1001-5000199430
London, England, United Kingdom (UK)51-200201153
Amersham, England, United Kingdom (UK)5001-1000018945
Paris, 脦le-De-France, France10001+198711
Geneva, Geneva, Switzerland10001+19452
Paris, 脦le-De-France, France11-50201712
Oberkochen, Baden-W眉rttemberg, Germany10001+18464
Paris, 脦le-De-France, France1001-5000199621
Moscow, Moscow, Russia201-50020070
Luxembourg1001-5000200516


Want to find more investors focusing on 欧博体育平台 spectacle lens manufacturing industry?

If you want to find more investors that are active in 欧博体育平台 spectacle lens manufacturingindustry, you can do that with Inven. We built this list and analysis throughInven's Investor Search, and 欧博体育平台re are a lot more private equity, venturecapital, and corporate investors like 欧博体育平台se globally.

With Inven, you'll also get to know:

  • Deal History: Number of deals and 欧博体育平台ir sizes.
  • Portfolio: Companies 欧博体育平台y've invested in.
  • Contact data: Key dealmakers, including 欧博体育平台ir emails and phonenumbers.
  • ...and much more!